Literature DB >> 1857324

Verapamil prevents cerebral acidosis during moderate hypoxia and hypotension.

A H Lockwood1, E W Yap.   

Abstract

Carotid ligation and moderate hypoxia in rats causes an increase in the glucose metabolic rate in the caudate-putamen and more widespread reductions in pH. Pretreatment of animals with verapamil did not affect the abnormality of glucose metabolism but abolished the associated acidosis. These data suggest that calcium channel blockade may protect the brain from injury during hypoxic hypoxia by preventing the development of acidosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1857324     DOI: 10.1007/bf01000380

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  6 in total

1.  Effects of moderate hypoxemia and unilateral carotid ligation on cerebral glucose metabolism and acid-base balance in the rat.

Authors:  A H Lockwood; K E Peek; M Izumiyama; E W Yap; J Labove
Journal:  J Cereb Blood Flow Metab       Date:  1989-06       Impact factor: 6.200

2.  Excessive cellular acidosis: an important mechanism of neuronal damage in the brain?

Authors:  S Rehncrona; I Rosén; B K Siesjö
Journal:  Acta Physiol Scand       Date:  1980-12

3.  Calcium channel blockers correct acidosis in ischemic rat brain without altering cerebral blood flow.

Authors:  L Berger; A M Hakim
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

Review 4.  The pathophysiology of brain ischemia.

Authors:  M E Raichle
Journal:  Ann Neurol       Date:  1983-01       Impact factor: 10.422

5.  Effect of nimodipine on the regional cerebral acidosis accompanying thiamine deficiency in the rat.

Authors:  S Vogel; A M Hakim
Journal:  J Neurochem       Date:  1988-10       Impact factor: 5.372

6.  Simultaneous double-isotope autoradiographic measurement of local cerebral glucose metabolic rate and acid-base status in rat brain.

Authors:  A H Lockwood; K E Peek; M Berridge; L Bogue; E Yap
Journal:  Metab Brain Dis       Date:  1987-03       Impact factor: 3.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.